DNA Form 144: Insider Plans to Sell 2,200 Shares Worth $24.6K on Jul 9 2025
Ginkgo Bioworks Holdings, Inc. (DNA) has filed a Form 144 indicating a proposed sale of 2,200 Class A shares through Fidelity Brokerage Services, valued at $24,596, with an expected trade date of 07/09/2025 on the NYSE.
Rhea-AI Filing Summary
Ginkgo Bioworks Holdings, Inc. (DNA) has filed a Form 144 indicating a proposed sale of 2,200 Class A shares through Fidelity Brokerage Services, valued at $24,596, with an expected trade date of 07/09/2025 on the NYSE. The filing states that 46,344,630 shares are outstanding, meaning the contemplated sale represents roughly 0.005 % of the public float—well below the Rule 144 limit of 1 % or the average-daily-volume test.
The “Securities Sold During the Past 3 Months” table lists Austin Che as having executed 52 separate transactions of 99 shares each, totaling 5,148 shares between 04/09/2025 and 06/23/2025. No aggregate proceeds figure is supplied, but individual sales ranged from $567 to $941 per lot. The upcoming 2,200-share sale therefore continues a pattern of small, periodic dispositions.
No financial results, operational updates, or corporate events are disclosed in this notice. From a capital-markets perspective, the filing merely provides advance disclosure of a minor insider sale and does not alter the company’s fundamentals or capital structure.
Positive
- None.
Negative
- None.
Insights
TL;DR: Minor insider sale; immaterial to DNA’s float and unlikely to influence valuation.
The Form 144 covers 2,200 shares—only about 0.005 % of the 46.3 million shares outstanding—well within Rule 144 limits. Historical data show 5,148 shares sold over the prior three months, reinforcing that the insider has been methodically trimming a small position. No adverse information about operations is asserted in the filing, and the dollar amounts involved are de-minimis relative to DNA’s market capitalization. Accordingly, the disclosure is neutral from a market-impact standpoint and should not materially affect investor sentiment or liquidity.
FAQ
What is the aggregate market value of the planned sale?
When is the insider planning to execute the sale?
Which broker will facilitate the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.